Skip to main content
. 2021 May 8;114(3):1208–1218. doi: 10.1093/ajcn/nqab112

TABLE 2.

Maternal 25(OH)D concentrations by BMI category throughout pregnancy and in umbilical cord at birth in each treatment group1

Baseline 28 gestational wk 36 gestational wk Umbilical cord
10 µg/d (n = 118) 20 µg/d (n = 121 P value 10 µg/d (n = 118) 20 µg/d (n = 121 P value 10 µg/d (n = 118) 20 µg/d (n = 121 P value 10 µg/d (n = 31 20 µg/d (n = 31 P value
25(OH)D, nmol/L
All 52.2 ± 22.9 52.0 ± 20.5 0.920 69.5 ± 25.6 82.8 ± 30.7 <0.001 80.8 ± 28.2 94.4 ± 33.2 <0.001 33.4 ± 12.8 36.4 ± 14.7 <0.001
Normal weight (n = 80) 55.9 ± 26.3 59.2 ± 19.8 0.516 71.4 ± 23.8 91.9 ± 27.8 <0.001 85.7 ± 25.0 106.7 ± 31.1 <0.001 35.6 ± 12.6 43.0 ± 14.3 <0.001
Overweight (n = 79) 51.0 ± 22.2 48.7 ± 18.7 0.620 72.9 ± 25.8 81.6 ± 29.6 <0.001 81.9 ± 24.9 93.9 ± 31.3 <0.001 33.8 ± 11.0 35.4 ± 14.0 0.005
Obese (n = 80) 49.7 ± 19.7 48.0 ± 21.2 0.716 64.3 ± 27.0 74.6 ± 32.2 0.092 74.8 ± 30.6 82.1 ± 33.4 0.480 30.7 ± 14.1 30.7 ± 12.8 0.855
1

Data are means ± SD. P differences in 25(OH)D between 10-µg/d and 20-µ/d treatment groups were assessed using a general linear model, adjusted for baseline 25(OH)D at 28 and 36 gestational wk and umbilical cord. Data at 28 and 36 gestational wk include imputed data; blood samples available for analysis at 28 gestational wk were n = 78 and n = 80, and at 36 gestational wk were n = 73 and n = 80, in the 10-µg/d and 20-µg/d treatment groups, respectively.